Literature DB >> 23160392

Neural stem cell grafts for complete spinal cord injury.

Yi Lu, Michael Y Wang.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23160392     DOI: 10.1227/01.neu.0000423041.74441.42

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  5 in total

1.  Tissue-Engineered Regeneration of Hemisected Spinal Cord Using Human Endometrial Stem Cells, Poly ε-Caprolactone Scaffolds, and Crocin as a Neuroprotective Agent.

Authors:  Panieh Terraf; Shideh Montasser Kouhsari; Jafar Ai; Hamideh Babaloo
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

2.  Effects of different sera conditions on olfactory ensheathing cells in vitro.

Authors:  Meng Lu; Jun Dong; Teng Lu; Hongjun Lv; Pinglin Yang; Zhijian Cheng; Jin Li; Baobao Liang; Junkui Xu; Haopeng Li; Xijing He
Journal:  Int J Mol Sci       Date:  2014-12-26       Impact factor: 5.923

3.  Tissue-engineered regeneration of completely transected spinal cord using induced neural stem cells and gelatin-electrospun poly (lactide-co-glycolide)/polyethylene glycol scaffolds.

Authors:  Chang Liu; Yong Huang; Mao Pang; Yang Yang; Shangfu Li; Linshan Liu; Tao Shu; Wei Zhou; Xuan Wang; Limin Rong; Bin Liu
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

4.  N-methyl-D-aspartate receptor antagonist MK-801 prevents apoptosis in rats that have undergone fetal spinal cord transplantation following spinal hemisection.

Authors:  Qiang Zhang; Yang Shao; Changsong Zhao; Juan Cai; Sheng Sun
Journal:  Exp Ther Med       Date:  2014-10-17       Impact factor: 2.447

5.  Interaction of iPSC-derived neural stem cells on poly(L-lactic acid) nanofibrous scaffolds for possible use in neural tissue engineering.

Authors:  Chengkai Lin; Chang Liu; Liangming Zhang; Zhi Huang; Peipei Zhao; Ruiqiang Chen; Mao Pang; Zhenxiang Chen; Liumin He; Chunxiao Luo; Limin Rong; Bin Liu
Journal:  Int J Mol Med       Date:  2017-11-30       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.